Lateral Sinus Augmentation Using L-PRF as Sole Graft Material
1 other identifier
interventional
18
0 countries
N/A
Brief Summary
Severe maxillary atrophy occurs after extraction of teeth in poster maxilla due to dimensional changes occur after removal; besides, sinus membrane pneumatization causes alveolar bone resorption, different classification for remaining alveolar bone in the posterior maxilla were done. In this study, the ABC sinus classification was followed in case selection. A sinus augmentation is done with several techniques. Sinus membrane elevation is done with two different approaches, either the crestal approach or lateral window approach. Using biofiller material for sinus membrane elevation has been tried by many researchers, using a bone graft, platelet concentrates preparation, collagen membranes, tenting screws, or with implant tenting. In this study, sinus augmentation was performed using a lateral window approach using L-PRF as sole biofiller material in one group, xenograft as only biofiller material in the second group and mixed xenograft with L-PRF in the third group. Histomorphometric analysis was done from the core biopsy after three months of augmentation, and implant placement was done. After three months, prosthetic parts were placed. The results of this study show that the augmentation of the sinus using L-PRF mixed with bone graft is showing the best results followed by L-PRF only, and the least was xenograft. From this point of discussion, it can be considered that using L-PRF as sole biofiller material in sinus augmentation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2016
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 26, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2019
CompletedFirst Submitted
Initial submission to the registry
September 8, 2019
CompletedFirst Posted
Study publicly available on registry
November 13, 2019
CompletedDecember 5, 2019
December 1, 2019
2.9 years
September 8, 2019
December 4, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
histomorphometric analysis
After three months from sinus augmentation, a second surgery will be done for implant placement; during this procedure, a bone core biopsy will be harvested. The biopsy will be stained with mason stain for histomorphometric analysis. The aim is to measure the newly formed bone for three months.
3 months
Study Arms (3)
L-PRF as sole graft material
EXPERIMENTALlateral sinus augmentation using L-PRF as sole graft material
xenograft as sole graft material
EXPERIMENTALlateral sinus augmentation using xenograft as sole graft material
Xenograft mixed with L-PRF as graft material
EXPERIMENTALlateral sinus augmentation using L-PRF mixed with xenograft as graft material
Interventions
sinus augmentation using L-PRF mixed with xenograft as sole graft material
sinus augmentation using xenograft as sole graft material
Eligibility Criteria
You may qualify if:
- Healthy adult patients.
- Both sex, males and females.
- Age from 24 - 49 years old.
- All patients were free from any systemic diseases as evidenced by Burkett's oral medicine health history questionnaire.
- Extraction done at posterior maxilla involved with the maxillary sinus.
- Remaining alveolar bone ≤ 5mm vertically and ≥ 4mm horizontally and from 1.5 mm to 3.5 mm vertically.
- Gingival biotype 1-2mm thickness.
- Patient has no previous surgery in Maxillary antrum.
You may not qualify if:
- Smokers.
- Pregnant and breast-feeding females.
- Mentally retarded Patients.
- Presence of hematologic disease.
- Previous radiation, chemotherapy, or immunosuppressive treatments.
- Diabetes mellitus, metabolic bone disease, ongoing treatment with bisphosphonates drugs, or pregnancy.
- Patient with history of chronic sinus pathosis
- Anticoagulant drugs, Endocarditis risk factors, renal and hepatic failure.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant lecturer
Study Record Dates
First Submitted
September 8, 2019
First Posted
November 13, 2019
Study Start
March 26, 2016
Primary Completion
March 1, 2019
Study Completion
April 1, 2019
Last Updated
December 5, 2019
Record last verified: 2019-12